Atrys Health

What Atrys Health does

Atrys Health S.A. is a Spanish precision-medicine company headquartered in Madrid and listed on Spain's Mercado Continuo (BME:ATRY) that operates across seven countries delivering diagnostic, oncology, telediagnostic, pathological anatomy, and nuclear medicine services to healthcare providers, corporate clients, and individual patients. The company's core product platform comprises four interconnected service lines: (1) oncology services spanning radiotherapy, medical oncology, and nuclear medicine across 8 treatment units in Spain, Portugal, and Mexico; (2) telediagnostics including proprietary teleradiology, telecardiology, and teledermatology platforms operating 24/7/365 with response times under 60 minutes for urgent cases and serving more than 500 connected centers; (3) genetic and molecular diagnostics anchored by what the company describes as the first private genetics laboratory in Spain and Portugal with a catalog of over 3,000 tests; and (4) the Smart Data / Big Pac health intelligence platform, which holds nearly 2 million anonymized patient records and weekly inputs from 550 pharmacies, used for predictive modeling and health economics analytics. Underlying technology includes proprietary cloud-based telemedicine platforms developed over 18+ years, Illumina NextSeq 550 and iScan sequencing platforms, and PET-CT/SPECT-CT imaging capabilities including radio-immunotherapy rooms operated at Hospital Sant Joan de Déu's pediatric cancer center through subsidiary SIMM Molecular.

Atrys generates revenue primarily through professional services and recurring B2B contracts with hospitals, healthcare institutions, and corporate occupational health clients (under the Aspy Prevention division prior to its 2025/2026 divestiture), supplemented by a direct-to-consumer telemedicine portal (portalpacientes.atryshealth.com) and direct genetic test sales. Pricing is quote-based and negotiated per contract with no public pricing disclosed; multi-year contracts are the norm for enterprise clients. The go-to-market is dual-track: enterprise field sales targeting hospitals, physicians, and corporate buyers alongside direct-to-consumer telemedicine for individual patients. Reported Q1 2026 revenue was €37.5 million (+6.3% YoY) with EBITDA of €4.1 million (+15.4% YoY). The customer base spans more than 500 connected telediagnostic centers, pathology samples received from more than 50 countries, and enterprise healthcare customers including HM Hospitales, Sanitas, Quirónsalud, Vithas, and MásMóvil. The company employs more than 850 professionals (over 1,400 when including prevention specialists prior to divestiture) and operates subsidiaries across Spain, Portugal, Switzerland, Mexico, Chile, Brazil, and Colombia.

Name

Atrys Health

Legal name

Atrys Health S.A.

Website

https://atryshealth.com

Company type

Public

Founded year

1997

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Atrys Health is a publicly traded Spanish precision-medicine company operating in seven countries, delivering oncology, telediagnostics, genetic diagnostics, and nuclear medicine services to healthcare providers, corporate clients, and individual patients.

Ownership category

akta.pro rank

Product category

Diagnostic Healthcare Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Diagnostic Imaging Centers (621512), Offices of Physicians (62111)

SIC

Services-Health Services (8000), Services-Hospitals (8060), Services-Medical Laboratories (8071)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Oncology Telemedicine Platforms (HLALAGAH), Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD), Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm) (HLACAIAF)

Keywords

• Diagnostic imaging services
• Oncology treatment services
• Telemedicine diagnostics
• Genetic testing services
• Precision medicine

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Oncology Services: Medical oncology and radiation oncology treatment services. Includes radiotherapy units, oncology infusion centers, and cancer treatment facilities across Spain, Portugal, and Mexico.
2. Telediagnostics Services: Remote diagnostic services including teleradiology, telecardiology, teledermatology, and pathological anatomy. B2B services to healthcare providers with 24/7 availability.
3. Diagnostic Imaging: Over 6.8 million online medical diagnostics delivered. Includes MRI, CT, mammography, and image post-processing laboratory services.
4. Genetic Diagnostics: Genetic testing services for patients and companies including cancer panels, prenatal testing, and pharmacogenomics. First private genetics laboratory in Spain.
5. Smart Data/Health Intelligence: Data analytics and health intelligence services for public health decision-making, health economics, and predictive modeling using Big Pac database.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

Atrys Health is a precision medical company operating in seven countries that provides diagnostic services and medical treatments across four integrated service lines: oncology (radiotherapy, medical oncology, and nuclear medicine), telediagnostics (teleradiology, telecardiology, and teledermatology), genetic and molecular diagnostics (including pathology services and 3,000+ genetic tests), and Smart Data health intelligence powered by the Big Pac database with nearly 2 million anonymized patient records. The company combines proprietary telemedicine platforms with on-site treatment units and 24/7 specialist availability to deliver precision medicine to individual patients, hospitals, and corporate clients.

Product overview

Atrys Health is a medical company operating in seven countries that provides precision healthcare services through a multi-product platform architecture. The core offering spans four main service lines: (1) Oncology Services including radiotherapy, medical oncology, and nuclear medicine with treatment units in Spain, Portugal, and Mexico; (2) Telediagnostics comprising teleradiology, telecardiology, and teledermatology for remote medical diagnostics; (3) Genetic and Molecular Diagnostics including pathology services and 3,000+ genetic tests; and (4) Smart Data/Big Pac health intelligence platform analyzing nearly 2 million patient records. Additional services include occupational health prevention, telemedicine consultations via patient portal, second opinion consultations, and research initiatives like the UB-Atrys Chair. The company operates through subsidiaries including SIMM Molecular (nuclear medicine), Bienzobas Salud (oncology), and Genetyca ICM (genetics), supported by over 850 medical professionals.

Differentiator

Problem solved

Functional benefit

Brands

• Big Pac: Spain's largest technology database with nearly 2 million health records used for health intelligence and data analytics.
• Atrys Oncology Network
• Patient Portal

Products and services

• Oncology Services Comprehensive cancer care including radiotherapy, medical oncology, and nuclear medicine delivered across 3 countries with 8 treatment units, 70+ oncologists, and 4 radiation oncology units in Spain, Portugal, and Mexico. Over 150,000 annual oncological procedures performed.
• Telemedicine (Patient Portal) Remote healthcare consultation platform providing access to specialists without travel. Patients receive specialized diagnosis, preventive consultations, and follow-ups through online sessions via the Patient Portal at portalpacientes.atryshealth.com.
• Teleradiology 24/7/365 radiological diagnosis service with 100+ specialized radiologists. Supports MRI, CT, mammography, and image post-processing. Emergency response within 1 hour, scheduled reports within 48 hours.
• Telecardiology Remote cardiology diagnostics with 1.5+ million electrocardiograms reported annually across 500+ connected centers. Services include ECG, Holter ECG, loop recording, ABPM, coronary CT, echocardiography, and cardiac MRI.
• Teledermatology Remote dermatology diagnostics using a proprietary platform with 18+ years experience. Processes 20M+ screenings and 5M+ imaging tests. Reports issued within 48 hours for skin cancer screening and dermatological control.
• Genetic Diagnostics First private genetics laboratory in Spain and Portugal with 3,000+ genetic tests in catalogue. Includes NGS sequencing panels, exome analysis, molecular oncology, and liquid biopsy services. Uses Illumina NextSeq 550 and iScan platforms for highest quality genetic analysis.
• Structural and Molecular Pathology Anatomical pathology service processing 300,000+ samples annually from 50+ countries. Offers 700+ tests including haematological tests, cytology, biopsies, and urgent consultations with 360-degree diagnostic reports.
• Smart Data / Big Pac Health Intelligence Health data analysis platform with Spain's largest technological database containing nearly 2 million anonymized patients. Monitors 550 pharmacies weekly, generates health intelligence for business decisions by healthcare companies and institutions. Supports predictive models and health economics analysis.
• Occupational Prevention Services Workplace health and safety services with 1,400+ prevention specialists across 200+ branches and partner centers. Includes integral prevention plans, occupational medicine, ergonomics, and psicosociology. Targeted at SMEs up to 250 workers and large enterprises with 250+ workers.
• Radiotherapy (IGRT) Image-Guided Single-Dose Radiotherapy (IGRT) enabling precise high-dose radiation application in single sessions. Reduces impact on healthy tissues and is applicable for early-stage tumor elimination.
• Nuclear Medicine Service Molecular and metabolic diagnostic imaging using PET-CT and SPECT-CT technologies. Includes radio-immunotherapy with lead-lined therapy rooms for treating pediatric and adult tumors with targeted radiopharmaceuticals.
• DNA Sequencing Kits Kits for DNA sequencing provided to patients for genetic testing, including non-invasive prenatal testing (BabyCare) and various genetic panels for cancer prevention, nutrition, and sports performance.

Quantifiable outcome

• Over 6.8 million online medical diagnostics delivered
• +5 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature5 records

Partnerships

Eight partnerships are on record, tiered strategic and core.

• COMPASS ConsortiumstrategicStrategic or Co-development Partner · 25 June 2026Largest European project on cancer-related cardiotoxicity. Initiative funded by Innovative Health Initiative with €50M+ budget. 62 academic and industrial partners from 25 countries. Coordinated by King's College London and GE HealthCare. Atrys contributes expertise in clinical genomics, pharmacogenomics and personalized medicine.
• Hospital Sant Joan de DéucoreStrategic or Co-development Partner · 8 February 2023Atrys and Hospital Sant Joan de Déu inaugurated Nuclear Medicine service at SJD Pediatric Cancer Center Barcelona. Atrys manages the service through subsidiary SIMM Molecular. Service benefits pediatric patients with tumors and other pathologies, with two lead-lined metabolic therapy rooms for radioimmunotherapy. Approximately 1,400 patients undergo diagnostic tests annually. Researchers from PCCB and SIMM will develop radioimmunotherapy markers for pediatric solid tumors.
• Bienzobas SaludcoreStrategic or Co-development Partner · 1 September 2022Acquisition of 100% of Bienzobas Salud, a subsidiary providing oncology services. Part of inorganic growth strategy.
• Fundación ChampalimaudcoreStrategic or Co-development Partner · 20 October 2021Collaboration agreement for joint diagnostic and oncology treatment procedures. Partnership focused on advancing precision medicine and diagnostic capabilities.
• Grupo Lusíadas SaúdecoreStrategic or Co-development Partner · 29 September 2021Agreement for installation of radiotherapy unit at Clínica de San Antonio in Lisbon, Portugal. Part of expansion strategy in Portuguese market.
• SanitascoreStrategic or Co-development Partner · 16 September 2021Partnership to open Instituto de Oncología Avanzada in Madrid. Advanced oncology institute combining expertise of both organizations.
• Grupo QuiróncoreImplementation/ SI/ Consulting Partner · 28 July 2021Llebalust Patología subsidiary signed agreement with Grupo Quirón for pathological anatomy services. Services provided to support diagnostic capabilities.
• VithasstrategicStrategic or Co-development Partner · 23 February 2021Scientific collaboration with new immunoassays based on technology developed by researchers from Mount Sinai Health System, New York. Focus on diagnostic innovation.

Scale indicators12 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Affidea: Pan-European diagnostic imaging and teleradiology network operating across 15 countries. Directly comparable to Atrys in teleradiology, imaging centers, and B2B healthcare-provider contracts; both compete for cross-border diagnostic volumes.
• GenesisCare: Global oncology treatment network offering radiotherapy, medical oncology, and integrated cancer care. Directly comparable to Atrys' oncology services business across Spain, Portugal, and Mexico; CEO Marian Isach previously held senior roles at GenesisCare Spain.
• Quirónsalud: Spain's largest private hospital network and a current Atrys partner (pathology services via Llebalust). Competes with Atrys in oncology and integrated diagnostics and represents both a customer and a potential vertical-integration threat.
• Vithas: Spanish private hospital group operating 20+ facilities, with whom Atrys has a scientific collaboration agreement on next-generation immunoassays. Direct peer in Spanish healthcare delivery and oncology service expansion.
• Unilabs: European clinical diagnostics and pathology laboratory network with significant operations in Spain and Portugal. Closely comparable to Atrys' pathology, molecular diagnostics, and genetic-testing business lines.

Broad incumbents

• Teladoc Health: Global leader in telemedicine and virtual care, offering telehealth, chronic-condition management, and AI-enabled diagnostics. Overlaps with Atrys' telemedicine and remote diagnostic specialties at a far larger scale, and serves as the public-market benchmark for the category.
• Koninklijke Philips: Diversified health technology incumbent with deep presence in diagnostic imaging, radiology informatics, and connected care. Competes with Atrys in teleradiology/AI imaging at significantly larger scale and R&D intensity.
• Siemens Healthineers: Global medical imaging, laboratory diagnostics, and digital health leader. Overlaps with Atrys' imaging, pathology, and oncology-radiotherapy adjacencies and co-coordinates the COMPASS European consortium alongside King's College London.

Emerging players

• Pro Medicus: Healthcare imaging IT and AI platform providing radiology PACS, AI decision support, and teleradiology workflows. Comparable technology overlap with Atrys' teleradiology platform, though Pro Medicus focuses on software rather than service delivery.
• Mevion Medical Systems: Specialized manufacturer of compact proton-therapy radiotherapy systems used in oncology centers. Adjacent/peer to Atrys' radiotherapy (IGRT) and oncology network as both supply technology into and compete for the same cancer-treatment capital projects.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Atrys_Health
• LinkedInlinkedin.com/company/atrys-health

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries15 records

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atrys Health